Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method

Theodore Arsenault; Collin M Labak; Kevin Chaung; Raymond F Muzic Jr; Arash Kardan; Andrew Sloan; Serah Choi; Tarun Podder; Zi Ouyang

doi:10.7759/cureus.19232

Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method

Cureus. 2021 Nov 3;13(11):e19232. doi: 10.7759/cureus.19232. eCollection 2021 Nov.

Authors

Theodore Arsenault¹, Collin M Labak², Kevin Chaung¹, Raymond F Muzic Jr³, Arash Kardan³, Andrew Sloan², Serah Choi¹, Tarun Podder¹, Zi Ouyang¹

Affiliations

¹ Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, USA.
² Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, USA.
³ Radiology, University Hospitals Cleveland Medical Center, Cleveland, USA.

Abstract

One of the treatment options for recurrent brain metastases is surgical resection combined with intracranial brachytherapy. GammaTile® (GT) (GT Medical Technologies, Tempe, Arizona) is a tile-shaped permanent brachytherapy device with cesium 131 (¹³¹Cs) seeds embedded within a collagen carrier. We report a case of treating a patient with recurrent brain metastases with GT and demonstrate a dosimetric modeling method.

Keywords: brachytherapy; dosimetry; gammatile; reccurent brain metastases; start.

Publication types

Case Reports

Grants and funding

K12 CA076917/CA/NCI NIH HHS/United States